UK markets closed
NIKKEI 225
27,402.05 +55.17 (+0.20%) HANG SENG
21,958.36 -113.82 (-0.52%) CRUDE OIL
76.81 +0.40 (+0.52%) GOLD FUTURES
1,927.90 -14.90 (-0.77%) DOW
34,000.36 -92.60 (-0.27%) BTC-GBP
19,661.17 +795.48 (+4.22%)
Sorrento Therapeutics, Inc. (0L85.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 05:57PM GMT
| Previous close | 0.9205 |
| Open | 0.9541 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.9523 - 1.0350 |
| 52-week range | 0.9523 - 1.0350 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 1.186M |
| Beta (5Y monthly) | 1.96 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses to 76%
It's not a secret that every investor will make bad investments, from time to time. But it's not unreasonable to try to...
- Motley Fool
Why Sorrento Therapeutics Stock Is on the Rise Today
The drugmaker's stock is moving upward today in sympathy with the broader biopharmaceutical industry.
- Motley Fool
Why Sorrento Therapeutics' Shares Tumbled 23.4% in September
What happened Shares of Sorrento Therapeutics (NASDAQ: SRNE), a biotech company that specializes in oncology and pain therapies, dropped 23.4% in September, according to data from S&P Global Intelligence.
© 2023 Yahoo. All rights reserved.
